Spectral Medical announced it received a deficiency letter from the FDA following its 100-day meeting regarding Toraymyxin, a therapeutic device designed to treat sepsis. The company stated the FDA did not request additional clinical trials and expects no delays in the regulatory timeline.
September 11, 2026 16:26 ET Consumer prices data was the main news on the economic front in the U.S. this week. In Europe, the latest interest rate decision from the European Central Bank was the focus along with the revised second quarter economic growth data for the euro area. In Asia, the monthly foreign trade data from China drew attention.